Alexion
Manufacturing · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
121 Seaport Blvd, Boston, Massachusetts,...Phone Number
(475) 230-2596Website
www.alexion.comRevenue
$1.4 BillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
10
10
1
2
2
2
About Alexion
Alexion is a global biopharmaceutical company focused on the discovery, development, and commercialization of medicines for severe and life-threatening rare disorders. The company was established in 1992 and is headquartered in Boston, Massachusetts.Explore more
Alexion Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alexion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Alexion launches new products
Check if Alexion has recently received funding, and reach out quickly before it becomes old news!
Alexion, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Alexion has new funding data
Click to see if Alexion had a recent Job posting/layoffs
Earning: See what the market has to say on Alexion recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Alexion
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Alexion is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Alexion as Masked Content
Find 2 more new buyers
Compare Similar Companies to Alexion
Compare insights from companies similar to Alexion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alexion
$1.4B
1K - 5K
Private
$18M
1992
MH
Mackenzie HalterOperations Senior Director, Strategy & Chief of Staff To, Regulatory & Safety Head of Development
Company Profile Activity
Activity Insights
Alexion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alexion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alexion.
Alexion financials insights
Gather financial insights about Alexion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1996
Stock Offering
$18M
Alexion Tech Stack
A closer look at the technologies used by Alexion
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Open Position
Open Position
Open Position
Alexion News & Media
New Interactive Storybook Aims to Educate Children with Rare Kidney Disease into a World of Adventure and Understanding
LONDON--(BUSINESS WIRE)--New Interactive Storybook Aims to Educate Children with Rare Kidney Disease into a World of Adventure and UnderstandingAstraZeneca CEO defends 'fantastic' Alexion buy as halts drug - Fierce Biotech
Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a $753 million hit for abandoning one of the drugs from that acquisition.< | AstraZeneca has ended development of its oral factor D inhibitor vemircopan, triggering a $753 million impairment charge as the drugmaker reevaluated the worth of its Alexion acquisition. The drugmaker took another charge in relation to last year’s $2 billion push into radiopharmaceuticals.KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--KOSELUGO Showed Significant and Clinically Meaningful Improvement in ORR Versus Placebo in Adults With NF1 who Have Symptomatic, Inoperable PNsAstraZeneca showcases strength of hematology portfolio and pipeline at ASH 2024
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca advances its ambition to redefine cancer care with new data across its industry-leading and diverse pipeline in hematology at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition December 7-10, 2024. A total of 57 abstracts will feature 13 approved and potential new medicines from across AstraZeneca’s portfolio and pipeline in hematology, including from Alexion, its rare disease group, with data in key settings including chro
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Alexion
Sign Up For FreeTo access detailed company insights
Alexion is a global biopharmaceutical company focused on the discovery, development, and commercialization of medicines for severe and life-threatening rare disorders. The company was established in 1992 and is headquartered in Boston, Massachusetts.... Read More
